Noriko Fukushi

Noriko Fukushi

Auto-generated profile, based on publicly available information

Noriko Fukushi

Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
JWJingyuan Wang
Jingyuan Wang
RMRyosuke Matsuura
Ryosuke Matsuura
SWSonoko Watanuki
Sonoko Watanuki
ABAronggaowa Bao
Aronggaowa Bao
NFNoriko Fukushi
Noriko Fukushi
YAYoko Aida
Yoko Aida
Bovine leukemia virus (BLV), the most prevalent neoplastic disease of cattle worldwide, is the causative agent of enzootic bovine leukosis. Polymorphisms in the bovine leukocyte antigen (BoLA)-DRB3 gene can influence host immune responses to pathogens, including BLV. However, the associations between specific BoLA-DRB3 alleles, BLV proviral load (PVL), a useful index for estimating disease progression and transmission risk, and BLV infection in Chinese cattle remain unknown. In this study, we identified 28 previously reported alleles in 289 Holstein cattle from Shandong Province, China, using polymerase chain reaction sequence-based typing. We further investigated whether BoLA-DRB3 polymorphisms influenced infection status and identified BoLA-DRB3*011:01 as an allele associated with susceptibility to BLV infection. An association analysis of allele frequencies between cattle with high and low PVL demonstrated that BoLA-DRB3*014:01:01 was significantly associated with low PVL. Farms with a higher frequency of cattle carrying BoLA-DRB3*014:01:01 had lower mean PVL values than farms with a lower frequency, indicating that resistant alleles are linked to low PVL levels. To our knowledge, this is the first study to demonstrate that BoLA-DRB3 polymorphisms associate with differential susceptibility to BLV infection and PVL in Holstein cattle in China. These findings may contribute to BLV control and eradication efforts through genetic selection.

Verified
Journal Article
Open access
PDF file
RMRyosuke Matsuura
Ryosuke Matsuura
MYMeripet Yamanaka
Meripet Yamanaka
NFNoriko Fukushi
Noriko Fukushi
SSSusumu Saito
Susumu Saito
KFKeisuke Fukumoto
Keisuke Fukumoto
YAYoko Aida
Yoko Aida
Bovine leukemia virus (BLV) causes enzootic bovine leukosis (EBL), yet its pathogenic mechanisms remain largely unclear. In particular, the role of BLV genomic integration sites (IS(s)) in BLV-induced leukemogenesis has not been fully elucidated. Here, we identified a total of 235 ISs from 99 BLV-infected cattle with lymphoma, of which 4.3% and 46.8% were located within exon and intron, respectively, while no preferential integration into CpG islands or repetitive regions was observed. All identified ISs were distinct, and no identical sites were detected among the samples. We identified 246 genes related with these ISs and protein–protein interaction analysis of these genes demonstrated one “IS-Clustered genes” composed of 85 among 246 genes. This “IS-Clustered genes” contains 12 cancer genes (14.1%) with high significantly proportion. Notably, with 55 among 99 cattle tested (55.6%) harboring ISs within this cluster, suggesting its crucial involvement in BLV-induced pathogenesis. Furthermore, integrated analysis of known lymphoma- and IS-related genes and the 85 “IS-Clustered genes” showed that key genes formed a shared cluster, indicating a potential “common EBL-associated cluster.” These findings provide important insights into the role of BLV integration in EBL development and may contribute to elucidating its molecular mechanisms underlying onset of EBL. In addition, these findings may also aid in the development of therapeutic strategies and facilitate early diagnosis.

28 January 2026 in HLA
Verified
Journal Article
Open access
NFNoriko Fukushi
Noriko Fukushi
MYMeripet Yamanaka
Meripet Yamanaka
RMRyosuke Matsuura
Ryosuke Matsuura
SWSonoko Watanuki
Sonoko Watanuki
SSSusumu Saito
Susumu Saito
YAYoko Aida
Yoko Aida
Bovine leukaemia virus (BLV) infects cattle, integrates into the host genome as a provirus, and induces a persistent infection that remains asymptomatic but can cause leukaemia/lymphoma. Most BLV‐infected cell clones are created by massive depletion, and a few of these infected cell clones expand through the mitotic cycle, leading to the onset of lymphoma. Bovine lymphocyte antigen (BoLA)‐DRB3 polymorphism is associated with susceptibility to BLV‐induced leukemogenesis. However, whether BoLA‐DRB3 polymorphism affects the clonality of BLV‐infected cells in vivo remains unknown. Here, we investigated whether lymphoma integration sites have specific features in cattle with varying susceptibility to lymphoma. Genomic DNA was extracted from 99 BLV‐infected Holstein cattle with lymphoma in a nationwide survey across Japan, and the integration sites were analysed using BLV proviral DNA‐capture sequencing, which we had previously developed. Among the integration sites identified in 99 animals, no identical sites were confirmed. Comparison of integration sites between cattle with susceptible and resistant BoLA‐DRB3 alleles showed no significant differences in the distribution of integration sites on the chromosome and in the genes and intergenic regions. With respect to the orientation of the proviruses, or proviral structures between individuals with resistance or susceptibility to lymphoma. In contrast, resistant animals showed a significantly higher proportion of monoclonal cell types than susceptible animals. In summary, the BoLA‐DRB3 polymorphism affects BLV clonality; for example, there is massive depletion and clonal expansion of infected cell clones in fully transformed clones obtained from BLV‐infected cattle with lymphoma.

4 February 2026 in Catalysts
Verified
Journal Article
Open access
PDF file
RMRyosuke Matsuura
Ryosuke Matsuura
SASaito Akatsuki
Saito Akatsuki
FNFumihiro Nagata
Fumihiro Nagata
NFNoriko Fukushi
Noriko Fukushi
Yasunobu MATSUMOTOYasunobu MATSUMOTO
Yasunobu MATSUMOTO
YAYoko Aida
Yoko Aida
The highly pathogenic avian influenza virus (HPAIV) is widely distributed worldwide and causes significant economic losses. Transmission of HPAIV occurs through direct contact between infected and susceptible birds or indirectly via contaminated materials. In recent years, airborne transmission of HPAIV has also been reported, underscoring the need for novel approaches to effectively inactivate airborne HPAIV. Photocatalysts have attracted significant attention as potential antiviral agents. In this study, we demonstrated that a TiO2-mediated photocatalytic reaction inactivated HPAIV and H1N1 seasonal influenza viruses in liquid, reducing their infectivity by 90.7% and 94.4%, respectively, after 60 min. Mechanistic analyses revealed decreased virion size and surface structure disruption, as determined by transmission electron microscopy. Additional evidence of viral protein and genome damage was obtained using Western blotting and RT-qPCR, respectively. Given the broad antiviral activity of photocatalysts, these findings suggest that they can inactivate influenza viruses regardless of strain or subtype. Notably, photocatalysts inactivated 80% of aerosolized H1N1 seasonal influenza viruses within 5 min. These results provide strong evidence that photocatalysts are capable of inactivating airborne influenza viruses. This study represents the first demonstration that photocatalysts can inactivate HPAIV and aerosolized influenza viruses. These findings provide strong evidence that photocatalysts represent a promising countermeasure against HPAIV, with potential applicability across different strains and subtypes.

2 October 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
Mohamed NayelMohamed Nayel
Mohamed Nayel
Samy KasemSamy Kasem
Samy Kasem
NFNoriko Fukushi
Noriko Fukushi
NENagwan El-Habashi
Nagwan El-Habashi
AEAhmed Elsify
Ahmed Elsify
HFHideto Fukushi
Hideto Fukushi
Equine herpesvirus type 1 (EHV-1) causes rhinopneumonitis, abortion, and neurological outbreaks (equine herpesvirus myeloencephalopathy, EHM) in horses. EHV-1 also causes lethal encephalitis in small laboratory animals such as mice and hamsters experimentally. EHV-1 ORF76 is a homolog of HSV-1 US9, which is a herpesvirus kinase. Starting with an EHV-1 bacterial artificial chromosome clone of neuropathogenic strain Ab4p (pAb4p BAC), we constructed an ORF76 deletion mutant (Ab4p∆ORF76) by replacing ORF76 with the rpsLneo gene. Deletion of ORF76 had no influence on replication, cell-to-cell spread in cultured cells, or replication in primary neuronal cells. In Western blots of EHV-1-infected cell lysates, an EHV-1 US9-specific polyclonal antibody detected multiple bands ranging from 35 to 42 kDa. In a CBA/N1 mouse infection model following intranasal inoculation, the parent and Ab4p∆ORF76 revertant caused the same histopathology in the brain and olfactory bulbs. The parent, Ab4p∆ORF76, and revertant mutant replicated similarly in the olfactory mucosa, although Ab4p∆ORF76 was not transported to the olfactory bulbs and was unable to infect the CNS. These results indicated that ORF76 (US9) plays an essential role in the anterograde spread of EHV-1.

7 April 2026 in Catalysts
Verified
Journal Article
Open access
PDF file
FNFumihiro Nagata
Fumihiro Nagata
RMRyosuke Matsuura
Ryosuke Matsuura
NFNoriko Fukushi
Noriko Fukushi
Yasunobu MATSUMOTOYasunobu MATSUMOTO
Yasunobu MATSUMOTO
TFTakashi Fukushima
Takashi Fukushima
YAYoko Aida
Yoko Aida
Aerosols are a major transmission route for seasonal influenza infections. Titanium dioxide (TiO2) photocatalyst has broad-spectrum antiviral activity, including in vitro influenza virus inactivation; however, whether the TiO2 photocatalyst can effectively inactivate airborne influenza A viruses in vivo under conditions that mimic natural aerosol transmission remains unclear. Here, we evaluated in vivo inactivation of airborne H1N1 seasonal influenza virus by a photocatalyst-equipped air purifier using a mouse model. Influenza virus WSN strain aerosols were sprayed in a 60 L acrylic box with a nebulizer, circulated through a photocatalyst-equipped air purifier, exposed to BALB/c mice for 40 min after circulation, and subsequently collected with an air sampler. Thirty minutes of TiO2 photocatalyst treatment reduced influenza virus infectivity by 99.97%, and significantly lowered lung viral titer in mice on day 3 post-infection. Over 14 days post-infection, mice showed no >10% weight loss, 100% survival, and disease progression to the PBS (−) aerosol group. This suggests that the photocatalyst-equipped air purifier may reduce H1N1 seasonal influenza onset, preventing viral spread.